Cell surface staining of recombinant factor VIII is reduced in apoptosis resistant BHK-21 cells

Journal of Biotechnology

Volumn 137, Issue 1-4, 2008, Pages 20-27

  Ishaque, Adiba ^a   Thrift, John ^a   Murphy, John E ^a   Konstantinov, K ^b  

^a BAYER CORPORATION   (United States)

^b GENZYME CORPORATION   (United States)

Author keywords

Apoptosis; BHK 21; Hsp70; rFVIII; Zenon

Indexed keywords

CELL DEATH; PAINTING;

APOPTOSIS; BHK-21; CELL SURFACES; HSP70; RFVIII; ZENON;

CELL MEMBRANES;

HEAT SHOCK PROTEIN 70; PHOSPHATIDYLSERINE; RECOMBINANT BLOOD CLOTTING FACTOR 8;

ANIMAL CELL; APOPTOSIS; ARTICLE; BATCH CELL CULTURE; CELL STRAIN BHK; CELL SURFACE; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING;

ANIMALS; APOPTOSIS; CELL LINE; CELL MEMBRANE; CELL SURVIVAL; CRICETINAE; FACTOR VIII; HSP70 HEAT-SHOCK PROTEINS; KIDNEY; MICROSCOPY, FLUORESCENCE; RECOMBINANT PROTEINS; STAINING AND LABELING;

ARMERIA; PSIDIUM;

EID: 52949115644     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2008.07.1856     Document Type: Article

References (20)

1. Arai M., Inaba H., Higuchi M., Antonarakis S.E., Kazazian Jr. H.H., Fujimaki M., and Hoyer L.W. Direct characterization of factor VIII in plasma: detection of a mutation altering a thrombin cleavage site (arginine-372-histidine). Proc. Natl. Acad. Sci. USA 86 (1989) 4277-4281
2. Chan, S., Tang, Y.H., Tao, Y., Wu, Y., Kelly, R., 2003. Use of molecular chaperones for the enhanced production of secreted recombinant proteins in mammalian cells. US Patent No.: US 2005/0048608 AI.
3. Fay P.J., Anderson M.T., Chavin S.I., and Marder V.J. The size of human factor VIII heterodimers and the effects produced by thrombin. Biochim. Biophys. Acta 871 3 (1986) 268-278
4. Gilbert G.E., Furie B.C., and Furie B. Binding of human factor VIII to phospholipid vesicles. J. Biol. Chem. 265 (1990) 815-822
5. Gilbert G.E., Drinkwater D., Barter S., and Clouse S.B. Specificity of phosphatidylserine-containing membrane binding sites for factor VIII. Studies with model membranes supported by glass microspheres (lipospheres). J. Biol. Chem. 267 (1992) 15861-15868
6. Henson P.M., Bratton V.A., and Fadok V.A. Apoptotic cell removal. Curr. Biol. 11 (2001) R795-R805
7. Ishaque A., and Al-Rubeai M. Use of intracellular pH and annexin-V flow cytometric assays to monitor apoptosis and its suppression by bcl-2 over-expression in hybridoma cell culture. J. Immunol. Methods 221 (1998) 43-57
8. Ishaque A., Thrift J., Murphy J.E., and Konstantin K. Over-expression of Hsp70 in BHK-21 cells engineered to produce recombinant factor VIII promotes resistance to apoptosis and enhances secretion. Biotechnol. Bioeng. Biotech. Bioeng. 97 (2007) 144-155
9. Kemball-Cook G., and Barrowcliffe T.W. Interaction of factor VIII with phospholipids: role of composition and negative charge. Throm. Res. 67 (1992) 57-71
10. Martin S.J., Finucane D.M., Amarante-Mendes G.P., O'Brien G.A., and Green D.R. Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. J. Biol. Chem. 271 (1996) 28753-28756
11. Martin K., Hart C., Liu J., Leung W.Y., and Patton W.F. Simultaneous trichromatic fluorescence detection of proteins on western blots using an amine reactive dye in combination with alkaline phosphate-and horseradish peroxidase-antibody conjugates. Proteomics 3 (2003) 1215-1217
12. Mikaelsson M., Oswaldsson U., and Sandberg H. Influence of phospholipids on the assessment of factor VIII activity. Haemophilia 4 (1998) 646-650
13. Raynal P., and Pollard H.B. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim. Biophys. Act 1197 (1994) 63-93
14. Saenko E.L., Shima M., Rajalakshmi K.J., and Scandella D. A role for the C2 domain of factor VIII in binding to von Willebrand factor. J. Biol. Chem. 269 (1994) 11601-11605
15. Saenko E., Sarafanov A., Greco N., Shima M., Loster K., Schwinn H., and Josic D. Use of surface plasmon resonance for studies of protein-protein and protein-phospholipid membrane interactions. Application to the binding of factor VIII to von Willebrand factor and to phosphatidylserine-containing membranes. J. Chromatogr. A 852 (1999) 59-71
16. Sakahira H., Enari M., and Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391 (1998) 96-99
17. Takeshima K., Smith C., Tait J., and Fujikawa K. The preparation and phospholipid binding property of the C2 domain of human factor VIII. Thromb. Haemost. 89 (2003) 788-794
18. Van den Eijnde S.M., Boshart L., Baehrecke E.H., DeZeeuw C.I., Reurelingserger C.P.M., and Vermeijikeers C. Cell surface exposure of phosphatidylserine during apoptosis is phylogenetically conserved. Apoptosis 3 (1998) 9-16
19. Vehar G.A., Keyt B., Eaton D., Rodriguez H., O'Brien D.P., Rotblat F., Oppermann H., Keck R., Wood W.I., Harkins R.N., et al. Structure of human factor VIII. Nature 5992 (1984) 337-342
20. Zwaal R.F., Comfurius P., and Bevers E.M. Lipid-protein interactions in blood coagulation. Biochim. Biophys. Acta 1376 (1998) 433-453